Co-Authors
This is a "connection" page, showing publications co-authored by KIM-ANH DO and ZIDING FENG.
Connection Strength
0.628
-
A Bayesian screening approach for hepatocellular carcinoma using multiple longitudinal biomarkers. Biometrics. 2018 03; 74(1):249-259.
Score: 0.147
-
Unbiased estimation of biomarker panel performance when combining training and testing data in a group sequential design. Biometrics. 2016 09; 72(3):888-96.
Score: 0.135
-
Improved Detection of Hepatocellular Carcinoma by Using a Longitudinal Alpha-Fetoprotein Screening Algorithm. Clin Gastroenterol Hepatol. 2016 Mar; 14(3):469-475.e2.
Score: 0.130
-
Biomarker trajectory for earlier detection of lung cancer. EBioMedicine. 2024 Oct; 108:105377.
Score: 0.061
-
Mortality Benefit of a Blood-Based Biomarker Panel for Lung Cancer on the Basis of the Prostate, Lung, Colorectal, and Ovarian Cohort. J Clin Oncol. 2023 09 20; 41(27):4360-4368.
Score: 0.056
-
Blood-Based Biomarker Panel for Personalized Lung Cancer Risk Assessment. J Clin Oncol. 2022 03 10; 40(8):876-883.
Score: 0.051
-
CES2 Expression in Pancreatic Adenocarcinoma Is Predictive of Response to Irinotecan and Is Associated With Type 2 Diabetes. JCO Precis Oncol. 2020 Nov; 4:426-436.
Score: 0.047